Quanta
Quanta Dialysis Technologies develops the FDA-cleared Quanta Dialysis System, a portable hemodialysis device offering all modalities on one platform via on-demand dialysate generation. The company sells capital equipment, disposables, and services to acute-care hospitals, dialysis clinics, and home patients.
- Company typePrivate
- Founded2008
- HeadquartersAlcester, United Kingdom
- Headcount101–250
- GTM typeB2B
- OfferingHardware or Manufacturing
What Quanta does
Quanta Dialysis Technologies Ltd is a UK-incorporated medical device company that develops the FDA-cleared Quanta Dialysis System, a 71-pound portable hemodialysis platform intended for use across the full continuum of care, from hospital ICUs to patient homes. Founded in 2008 and headquartered in Warwick, UK with US operations based in Beverly, Massachusetts, the company's flagship device uses proprietary on-demand dialysate generation technology with pneumatic membrane pumps housed in single-use cartridges. This architecture eliminates the need for pre-mixed dialysate bags and harsh chemical disinfections, and the system is the first and only FDA-cleared device offering all hemodialysis modalities—IHD, SLED, CRRT, and home hemodialysis—on a single platform. Quanta also markets the Quanta Cart mobility accessory, the CareLinQ cloud-based digital health platform, and single-use disposables (dialysate cartridge and blood tubeset).
The company monetizes through a multi-stream capital-and-consumable model: sales of the Quanta Dialysis System as capital equipment, recurring revenue from single-use dialysate cartridges and blood tubesets required per treatment, and 24/7 service and support contracts. Go-to-market is enterprise field sales targeting acute-care hospitals, dialysis providers, and dialysis clinic networks, with a direct US sales force, demonstration programs, and clinical pilots as the lead-conversion mechanism. Key disclosed customers include Innovative Renal Care (multi-year strategic agreement announced September 2025), MercyOne Waterloo Medical Center (pilot with 130+ treatments since February 2025), and Legacy Dialysis (Virginia clinic case study). Pricing is not publicly disclosed and contracts are typically multi-year.
Quanta is privately held and venture-backed, having raised over $353 million across disclosed funding rounds, including a $245M Series D in 2021—the largest private financing ever for a dialysis device company—and an oversubscribed $60M+ Series E in 2024. Strategic and institutional investors include Novo Holdings and Glenview Capital (co-leads of both Series D and Series E), with b2venture participating as a recurring investor. The company is led by CEO Alejandro Galindo (appointed November 2022, prior executive roles at Medtronic and MannKind), with a leadership bench drawn from Medtronic, GE Healthcare, and MannKind, and a board including Glenview Capital representation and former CMS acting administrator Leslie Norwalk. Manufacturing is supported by a partnership with Benchmark Electronics.
Quanta firmographics
Firmographics- Name
- Quanta
- Legal name
- Quanta Dialysis Technologies Limited
- Website
- https://quantadt.com
- Company type
- Private
- Founded year
- 2008
- Operating status
- Operating
- Headcount range
- 101–250 employees
- Short description
- Quanta Dialysis Technologies develops the FDA-cleared Quanta Dialysis System, a portable hemodialysis device offering all modalities on one platform via on-demand dialysate generation. The company sells capital equipment, disposables, and services to acute-care hospitals, dialysis clinics, and home patients.
- Ownership category
- akta.pro rank
Quanta industry classification
Industry- Product category
- Hemodialysis Medical Devices
- NAICS
- Kidney Dialysis Centers (621492), Medical, Dental, and Hospital Equipment and Supplies Merchant Wholesalers (423450)
- SIC
- Wholesale-Machinery, Equipment & Supplies (5080)
- akta.pro primary industry
- Hemodialysis Machines & Systems (HLAHAKAA)
- akta.pro secondary industries
- Peritoneal Dialysis (PD) Systems & Supplies (HLAHAKAB), Renal Replacement Therapy Consumables (Bloodlines, Filters, Cartridges) (HLAHAKAH), Home Dialysis Support & Training Providers (HLAFAEAG)
Keywords
Where Quanta is headquartered
LocationHeadquarters
- HQ city
- Alcester
- HQ country
- United Kingdom
- HQ region
- Europe
Offices3 records
Markets served
Quanta business model
Business model- GTM type
- B2B
- Offering type
- Hardware or Manufacturing
- Cost components
- Technology or R&D, Personnel, Supply Chain, Operations, Marketing or Sales, Infrastructure
Revenue model
- Dialysis Equipment Sales: Sale of Quanta Dialysis System machines to hospitals, dialysis clinics, and healthcare providers. The device is sold as capital equipment with associated disposables.
- Disposables and Consumables: Single-use blood tube sets, dialysate cartridges, and other consumables required for each treatment session.
- Service and Support: 24/7 customer care, technical support, and maintenance services. Option for customers to use Quanta's full-service solution for machine repair/replacement.
Pricing tiers
| Model | Billing | Price |
|---|---|---|
| Other | Multi-year contract | Quanta Dialysis System capital equipment - enterprise pricing |
Go-to-market motion2 records
Distribution channels3 records
Marketing channels5 records
Quanta product offering
Product offeringCore offering
Quanta develops and commercializes the Quanta Dialysis System, a compact 71 lbs portable hemodialysis machine that delivers all hemodialysis modalities (IHD, SLED, CRRT, and Home HD) from a single FDA-cleared platform using proprietary on-demand dialysate generation technology. The company sells capital equipment to hospitals and dialysis providers along with recurring disposable cartridges, blood tubesets, the Quanta Cart mobility accessory, and the cloud-based CareLinQ Digital Health Platform.
Product overview
Quanta Dialysis Technologies offers a single unified product platform, the Quanta Dialysis System (formerly SC+ Hemodialysis System), supplemented by a mobility accessory (Quanta Cart), a digital health platform (CareLinQ), and single-use disposables (Dialysate Cartridge and Blood Tubeset). The core Quanta Dialysis System is a compact portable hemodialysis machine that provides all hemodialysis modalities—IHD, SLED, CRRT, and home hemodialysis—on one platform using on-demand dialysate generation technology, eliminating the need for dialysate bags. The Cart provides mobility and water system integration, while CareLinQ enables cloud connectivity, fleet management, and eLearning. All products work exclusively within the Quanta ecosystem.
Differentiator
Problem solved
Functional benefit
Products and services
- Quanta Dialysis System FDA-cleared portable hemodialysis system and the first and only device offering every hemodialysis modality (IHD, SLED, CRRT, and Home HD) in one platform without the need for dialysate bags. The compact 71 lbs device features on-demand dialysate generation, an intuitive touchscreen interface, wide Qd range of 50-500 mL/min, and requires only a once-weekly hot rinse maintenance.
- Quanta Cart Portable mobility cart with sturdy design and locking wheels for transport of the Quanta Dialysis System. Compatible with Mar Cor portable reverse osmosis systems (WRO 300H and Eon) and prefiltration system, featuring storage drawer, tap for collecting post-carbon samples, and hooks for organizing fluid lines.
- CareLinQ Digital Health Platform Cloud-based digital health platform designed to reduce paperwork and charting burden, improve fleet management, and support QAPIs through actionable analytical insights. Includes on-demand eLearning modules for staff onboarding and machine-connectivity for real-time troubleshooting by the Customer Care team.
- Dialysate Cartridge (Model Nos: SC-13617 & SC-14354) Single-use disposable cartridge with proprietary on-demand dialysate generation technology that eliminates the need for pre-mixed dialysate bags. Incorporates pneumatic membrane pumps for accurate, consistent flow rates and is covered by granted patents including EP2442847, US9682183, and others.
- Blood Tubeset Single-use disposable arterial and venous bloodline set providing extracorporeal access during hemodialysis. Compatible exclusively with the Quanta Dialysis System.
Quantifiable outcome
- 45-54% cost savings vs CRRT for health systems
- +4 more outcomes
Companies that use Quanta
Customer profileNamed customers3 records
Segments4 records
Ideal customer profiles3 records
Quanta technology and API
TechnologyTechnology focussed Yes
API detail
- Has API
- No
- API docs
- API detail
Core technology
AI maturity
App detail
Integration2 records
Feature4 records
Quanta partnerships and signals
Strategic signalPartnerships
Two partnerships are on record, tiered core and major.
- Innovative Renal Care (IRC)coreMulti-year strategic agreement to broaden access to Quanta Dialysis System within select IRC programs nationwide. Following successful pilot at MercyOne Waterloo Medical Center with 130+ treatments, IRC and Quanta finalized purchase agreement covering capital equipment, disposables, and EMR integration options.
- Benchmark ElectronicsmajorManufacturing partner selected for production of SC+ hemodialysis system. Benchmark is a global provider of manufacturing, engineering, and design services (NYSE: BHE).
Scale indicators8 records
Recent moves6 records
Expansion highlights5 records
Quanta competitors and assessment
Company assessmentBroad incumbents
- DaVita: DaVita is one of the two dominant US dialysis providers, operating thousands of clinics; while primarily a service provider, it is a major buyer of dialysis capital equipment and a key account target for Quanta's enterprise sales motion.
- Baxter International: Baxter's Renal Care segment supplies PD and HD devices, dialyzers, and CRRT systems globally; its broad MedTech portfolio overlaps with Quanta's acute-care and home dialysis offerings across established hospital channels.
- B. Braun: B. Braun's Avitum division manufactures hemodialysis machines, CRRT systems, and dialyzers, making it a long-established European competitor with comparable acute-care and chronic dialysis product lines to Quanta.
- Fresenius Medical Care: Fresenius is the global leader in dialysis products and services (owns NxStage), with a broad portfolio spanning hemodialysis machines, dialyzers, and provider clinics that compete with Quanta across both device sales and integrated care delivery.
- Asahi Kasei Medical:
Direct peers
- Outset Medical: Outset Medical makes Tablo, a portable hemodialysis system cleared for hospital and home use, and is Quanta's closest direct competitor in compact, multi-modality dialysis devices targeting US acute-care and home markets.
Market position
Strengths5 records
Weaknesses5 records
Competitive moat5 records
Key risks6 records
Key highlights7 records
Customer concentration
Quanta social profiles
Digital presenceQuanta compliance and trust
Trust signalCompliance3 records
Quanta financial estimates
Financial estimateRevenue estimate
Valuation estimate
Quanta leadership team
Management profileNumber of profiles
Profiles17 records
Quanta funding detail
Funding detailFunding overview
Funding rounds6 records
Investors20 records
Funding detail is available on the Subscription and Enterprise plan.Contact sales →
Quanta M&A and investment
M&A and investmentM&A
Investments
M&A and investment is available on the Subscription and Enterprise plan.Contact sales →
Frequently asked questions about Quanta
What does Quanta do?
Quanta develops and commercializes the Quanta Dialysis System, a compact 71 lbs portable hemodialysis machine that delivers all hemodialysis modalities (IHD, SLED, CRRT, and Home HD) from a single FDA-cleared platform using proprietary on-demand dialysate generation technology. The company sells capital equipment to hospitals and dialysis providers along with recurring disposable cartridges, blood tubesets, the Quanta Cart mobility accessory, and the cloud-based CareLinQ Digital Health Platform.
Is Quanta a public or private company?
Quanta is a private company. It is classified as venture growth investor backed and is currently operating.
When was Quanta founded?
Quanta was founded in 2008. It employs 101 to 250 people.
Where is Quanta based?
Quanta is headquartered in Alcester, United Kingdom, in the Europe region.
How does Quanta make money?
Three revenue lines are on record. Dialysis Equipment Sales are the primary driver. The others are disposables and Consumables and service and Support.
Who are Quanta's main competitors?
Broad incumbents on record are DaVita, Baxter International, B. Braun, Fresenius Medical Care and Asahi Kasei Medical. Outset Medical is listed as a direct peer.
Does Quanta have an API?
No public API is recorded for Quanta.
What industry is Quanta in?
Quanta's product category is Hemodialysis Medical Devices. Its primary akta.pro industry code is HLAHAKAA, Hemodialysis Machines & Systems, with a secondary code of HLAHAKAB, Peritoneal Dialysis (PD) Systems & Supplies. Its NAICS code is 621492 and its SIC code is 5080.